Blood-Based Biomarkers Are Advancing Alzheimer’s Testing
Blood-based biomarker tests are revolutionizing Alzheimer's diagnostic testing and management of Alzheimer’s disease.
Latest Articles
Editor's Top Picks
Are AI-Powered Neurodiagnostic Solutions the New Frontier in Alzheimer’s Prevention?
AI-enhanced EEG technology offers a promising, accessible way to detect early signs of Alzheimer’s disease—years before symptoms appear.
Critical Resources
Diagnostic Innovations
Scopio Labs Receives FDA Clearance for Decision Support System on X100 and X100HT Platforms
Scopio Labs has received its fourth FDA clearance for enhanced decision support features in its X100 and X100HT platforms.
Equipment & Supply Spotlight
EXAONE Path 2.0 Next-Generation Precision Medical AI Debuts
LG AI Research has launched EXAONE Path 2.0, a cutting-edge precision medical AI model that predicts gene mutations and biological markers.
News, Know-How & Standards
Disease Detection & Understanding
Proteins in the Blood Can Reveal the Severity Malaria
Researchers have identified over 250 proteins strongly affected by malaria, offering potential biomarkers to predict disease severity.
